Evaluation of serum level of homocysteine, vitamin b12 and zinc in patients with acute ischaemic stroke in zaria

Project Abstract

<p> </p><p>Stroke has been a global burden, with increasing morbidity and mortality. Several risk factors have been identified, which include hyperhomocysteinaemia, hypovitaminosis B12, and low zinc levels, which are the now target of preventive strategies. Limited studies have been done on the risk factors (analytes) in our environment hence the current study was undertaken to evaluate the serum levels of homocysteine, vitamin B12 and zinc in patients with acute ischaemic stroke in Zaria and healthy controls. One hundred ischaemic stroke patients on admission confirmed by brain CT-scan or Siri-raj stroke score of less than minus one.(-1) and equal number of apparently healthy age and sex-matched were recruited. Their serum homocysteine, and vitamin B12 were measured using enzyme linked Immunosorbent assay,and zinc was measured using direct colorimetric method. Stroke severity was determined using National Institute of Health Stroke Score (NIHSS). Mean serum homocysteine for patients was significantly higher than that of controls (p&lt;0 .05=”” and=”” b=”” mean=”” serum=”” span=”” vitamin=””&gt;12and zinc were significantly lower compared to that of controls (p&lt;0 -1.70=”” .05=”” 0.04=”” 0.19=”” 0.54=”” 0.90=”” 199.72-685.48pg=”” 52.26-111.86=”” an=”” and=”” b=”” be=”” controls=”” dl=”” for=”” found=”” from=”” g=”” healthy=”” homocysteine=”” intervals=”” l=”” ml=”” mol=”” obtained=”” odds=”” of=”” ratio=”” reference=”” respectively.=”” span=”” the=”” to=”” vitamin=”” were=”” with=””&gt;12 and zinc respectively. Hyperhomocysteinaemia was seen in 34%, hypovitaminosis B12 was seen in 81% and low zinc was seen in 46%. Patients with hyperhomocysteinaemia, hypovitaminosis B12 and low zinc presented with more severe neurologic deficits even though the difference was not statistically significant with p-values of 0.946, 0.735, and 0.566 respectively. Elevated serum homocysteine, low vitamin B12 and zinc were found to be associated with ischaemic stroke. There was negative correlation between homocysteine and vitamin B12 and stroke severity and therefore early management of those conditions may be an effective way of decreasing the incidence of stroke in our environment. Vitamin B12 and zinc supplements may be beneficial to patients at risk.</p><p>&nbsp;</p> <br><p></p>

Project Overview

<p> </p><p><strong>1.0 &nbsp;</strong><strong>INTRODUCTION</strong></p><p><strong>1.1 &nbsp;</strong><strong>BACKGROUND</strong></p><p>Stroke is defined as a clinical syndrome of sudden onset of rapidly developing symptoms or signs of focal and at times global loss of cerebral function, with symptoms lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin (Kameshwar<em>et al</em>, 2012).</p><p>The World Health Organization estimates that cardiovascular disease and stroke will be the leading cause of death and disability world wide by 2020 (Lynn,2000). Stroke is one of the leading causes of death in any population, and its prevention is a key strategy in reducing the rate of mortality and morbidity (Hoseinali<em>et al</em>, 2011). It is the third commonest cause of death in Western industrialised countries (James <em>et al</em>,2000). Stroke is presently the leading cause of disability and the third leading cause of death in United States (US centers, 2007). In the United States, blacks have an age-adjusted risk of death from stroke that is 1.49 times that of whites (Schneider <em>et al,</em>&nbsp;2004). More than 700,000 persons per year suffer a first time stroke in the United States with 20% of these individuals dying within the first year after stroke (American Heart Association, 2002).If current trend continues, this number is projected to reach one million per year by the year 2020(Ralph <em>et al,</em>&nbsp;1997). In low income and middle income countries, the burden of stroke and other vascular diseases is likely to increase substantially over time in the next few decades because of their expected health and demographic transition (Ralph<em>et al</em>, 1997).</p><p>Globally in 2005, it was estimated that stroke caused 5.7 million deaths, and 87% of these occurred in low income and middle-income countries of the world (Strong <em>et al,</em>&nbsp;2007)…..</p> <br><p></p>